Study Reports Woman's age and size of Tumor Influences Breast Cancer Survival

According to a study done by the Australian Institute of Health and Welfare on more than 100,000 women, the major factors that influence breast cancer survival are the woman's age and size of the tumor at time of diagnosis. These researchers noted that the five-year survival rate is 98 percent if the tumor is less than 10 millimeters in diameter at the time of diagnosis, compared with 95 percent for 11 to 15mm neoplasms, 93 percent for tumors 16 to 19mm, 88 percent for tumors 20 to 29 mm, 73 percent for tumors larger than 30 mm, and 49 percent for tumors of unknown size. Scientists there also found that women between 50 and 59 years old had a 90 percent five year survival rate after a breast cancer diagnosis irrespective of tumor size compared with 86 percent for women in their 30s and younger. According to Helen Zorbas, director of the National Breast Cancer Center in Australia, younger women in the study usually had more aggressive tumors.

She added that more research needs to be done to determine why this occurs and what can be done about it. Zorbas concluded by saying that these findings emphasize the importance of routine screening to detect breast cancer in the early stages.


Correlation between Size and Shape of Hips and Risk of Breast Cancer

And in another study, scientists at Oregon Health & Science University discovered a strong correlation between the size and shape of a woman's hips and her daughter's risk of breast cancer. Wide, round hips, the researchers postulated, represent markers of high sex hormone concentrations in the mother, which increase her daughter's vulnerability to breast cancer.

The results of this study suggest that breast cancer originates in the first three months of a pregnancy during which time the embryo's developing breast tissue is exposed to the mother's circulating hormones. "Our findings support the hypothesis that wide round hips reflect high levels of sex hormone production at puberty, which persist after puberty and adversely affect breast development of the daughters in early gestation," the authors commented. They added, "High...estrogen concentrations in the maternal circulation could produce genetic instability in differentiating breast epithelial cells, which would make the breast vulnerable to cancer in later life."

Programs from our Oncology Library that discuss all aspects of breast cancer include:


Volume 1, Number 15
November 15, 2007

NURSE'S CORNER

One of Hot Topics' goals is to address matters of greatest interest and concern in nurse educators' lives. We do that in a number of ways, through research, the media, and more. You can help too, by sending us topics you want to learn or know more about. Please email us at hottopics@conceptmedia.com and share how we can make this a more effective tool for you. We will address your topic and attribute the request to you and your organization. We look forward to hearing from you.



Osteoporosis Drug, Raloxifene, May Reduce Chance of Developing Breast Cancer

In related news, a large government-sponsored study of nearly 20,000 post-menopausal women, found that the drug raloxifene, which is used to treat osteoporosis, may also reduce their chance of developing breast cancer as effectively as tamoxifen, which is the only drug shown to date that can lower their risk. A preliminary analysis of the data indicated that raloxifene cut the risk of breast cancer by 50 percent. The women taking this drug also had fewer side effects associated with tamoxifen such as uterine cancers, blood clots, and cataracts.

Despite these findings, several experts were cautious, saying that the advantage of raloxifene is still uncertain and that more research is needed to prove the drug reduced the overall risk over longer periods.


Recent Hot Topics
Contact Us

We would like to hear from you. Please email us on any topics you would like to see covered in Hot Topics.

hottopics@conceptmedia.com. Or call us at (800) 233-7078.

This Hot Topics was delivered to you by Concept Media. You can take your email address off Concept Media's email list. If you request to be taken off Concept Media's email list, Concept Media will honor your request pursuant to our permission-based email terms and conditions. Postal address: 2493 DuBridge Ave., Irvine, CA 92606-5022